VAISHALI PHARMA
|
VAISHALI PHARMA Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
Equity - Authorised | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹11 Cr | ₹11 Cr |
Equity - Issued | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
Equity Paid Up | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹7.03 Cr | ₹7.56 Cr | - | - | - |
Total Reserves | ₹25 Cr | ₹22 Cr | ₹16 Cr | ₹12 Cr | ₹11 Cr |
Securities Premium | ₹10 Cr | ₹8.07 Cr | ₹8.10 Cr | ₹8.20 Cr | ₹8.20 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹15 Cr | ₹14 Cr | ₹7.59 Cr | ₹3.57 Cr | ₹2.52 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹0.18 Cr | ₹0.16 Cr | ₹0.12 Cr | ₹0.11 Cr | ₹0.11 Cr |
Reserve excluding Revaluation Reserve | ₹25 Cr | ₹22 Cr | ₹16 Cr | ₹12 Cr | ₹11 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹43 Cr | ₹41 Cr | ₹26 Cr | ₹22 Cr | ₹21 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹4.99 Cr | ₹6.32 Cr | ₹3.81 Cr | ₹5.68 Cr | ₹4.75 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹4.33 Cr | ₹5.46 Cr | ₹2.76 Cr | ₹4.54 Cr | ₹4.01 Cr |
Term Loans - Institutions | ₹0.66 Cr | ₹0.86 Cr | ₹1.05 Cr | ₹1.14 Cr | ₹0.74 Cr |
Other Secured | - | - | - | - | - |
Unsecured Loans | ₹-1.39 Cr | ₹-1.09 Cr | ₹-0.70 Cr | ₹-1.64 Cr | ₹-0.70 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | ₹-1.39 Cr | ₹-1.09 Cr | ₹-0.70 Cr | ₹-1.64 Cr | ₹-0.70 Cr |
Deferred Tax Assets / Liabilities | ₹-0.18 Cr | ₹-0.14 Cr | ₹-0.16 Cr | ₹-0.15 Cr | ₹-0.12 Cr |
Deferred Tax Assets | ₹0.18 Cr | ₹0.14 Cr | ₹0.16 Cr | ₹0.15 Cr | ₹0.12 Cr |
Deferred Tax Liability | - | - | - | - | - |
Other Long Term Liabilities | ₹0.24 Cr | ₹0.88 Cr | ₹0.04 Cr | ₹0.23 Cr | ₹0.22 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹0.20 Cr | ₹0.19 Cr | ₹0.19 Cr | ₹0.19 Cr | ₹0.14 Cr |
Total Non-Current Liabilities | ₹3.86 Cr | ₹6.16 Cr | ₹3.17 Cr | ₹4.30 Cr | ₹4.28 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹19 Cr | ₹18 Cr | ₹28 Cr | ₹41 Cr | ₹24 Cr |
Sundry Creditors | ₹19 Cr | ₹18 Cr | ₹28 Cr | ₹41 Cr | ₹24 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹6.05 Cr | ₹4.76 Cr | ₹5.56 Cr | ₹6.71 Cr | ₹5.08 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹2.72 Cr | ₹1.76 Cr | ₹2.50 Cr | ₹2.11 Cr | ₹1.80 Cr |
Interest Accrued But Not Due | ₹0.01 Cr | ₹0.01 Cr | ₹0.02 Cr | - | ₹0.01 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹3.32 Cr | ₹3.00 Cr | ₹3.04 Cr | ₹4.60 Cr | ₹3.27 Cr |
Short Term Borrowings | ₹7.62 Cr | ₹7.34 Cr | ₹17 Cr | ₹12 Cr | ₹12 Cr |
Secured ST Loans repayable on Demands | ₹7.08 Cr | ₹6.68 Cr | ₹11 Cr | ₹12 Cr | ₹12 Cr |
Working Capital Loans- Sec | ₹7.08 Cr | ₹6.68 Cr | ₹11 Cr | ₹12 Cr | ₹12 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-6.54 Cr | ₹-6.02 Cr | ₹-5.75 Cr | ₹-12 Cr | ₹-11 Cr |
Short Term Provisions | ₹0.03 Cr | ₹1.97 Cr | ₹1.31 Cr | ₹0.39 Cr | ₹0.08 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | ₹1.95 Cr | ₹1.27 Cr | ₹0.38 Cr | ₹0.06 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.03 Cr | ₹0.02 Cr | ₹0.04 Cr | ₹0.02 Cr | ₹0.02 Cr |
Total Current Liabilities | ₹33 Cr | ₹32 Cr | ₹52 Cr | ₹59 Cr | ₹40 Cr |
Total Liabilities | ₹80 Cr | ₹79 Cr | ₹81 Cr | ₹86 Cr | ₹66 Cr |
ASSETS | |||||
Gross Block | ₹3.89 Cr | ₹3.85 Cr | ₹3.30 Cr | ₹2.89 Cr | ₹2.73 Cr |
Less: Accumulated Depreciation | ₹2.37 Cr | ₹1.86 Cr | ₹2.12 Cr | ₹1.67 Cr | ₹1.24 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹1.52 Cr | ₹1.98 Cr | ₹1.18 Cr | ₹1.22 Cr | ₹1.49 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | - | - | - |
Non Current Investments | ₹0.43 Cr | ₹0.43 Cr | ₹0.43 Cr | ₹0.43 Cr | ₹0.43 Cr |
Long Term Investment | ₹0.43 Cr | ₹0.43 Cr | ₹0.43 Cr | ₹0.43 Cr | ₹0.43 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.43 Cr | ₹0.43 Cr | ₹0.43 Cr | ₹0.43 Cr | ₹0.43 Cr |
Long Term Loans & Advances | ₹0.93 Cr | ₹1.43 Cr | ₹1.43 Cr | ₹0.96 Cr | ₹0.93 Cr |
Other Non Current Assets | ₹1.64 Cr | ₹1.56 Cr | ₹1.50 Cr | ₹2.03 Cr | ₹1.94 Cr |
Total Non-Current Assets | ₹5.26 Cr | ₹6.08 Cr | ₹5.04 Cr | ₹4.68 Cr | ₹4.87 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹0.38 Cr | ₹3.05 Cr | ₹0.63 Cr | ₹0.59 Cr | ₹0.88 Cr |
Raw Materials | - | - | - | - | - |
Work-in Progress | - | - | - | - | - |
Finished Goods | - | - | - | - | - |
Packing Materials | - | - | - | - | - |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹0.38 Cr | ₹3.05 Cr | ₹0.63 Cr | ₹0.59 Cr | ₹0.88 Cr |
Sundry Debtors | ₹49 Cr | ₹54 Cr | ₹59 Cr | ₹67 Cr | ₹47 Cr |
Debtors more than Six months | ₹26 Cr | ₹37 Cr | ₹35 Cr | ₹34 Cr | ₹33 Cr |
Debtors Others | ₹23 Cr | ₹17 Cr | ₹24 Cr | ₹33 Cr | ₹14 Cr |
Cash and Bank | ₹1.58 Cr | ₹0.99 Cr | ₹1.36 Cr | ₹0.47 Cr | ₹0.38 Cr |
Cash in hand | ₹0.17 Cr | ₹0.06 Cr | ₹0.23 Cr | ₹0.23 Cr | ₹0.16 Cr |
Balances at Bank | ₹1.41 Cr | ₹0.93 Cr | ₹1.13 Cr | ₹0.24 Cr | ₹0.22 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.47 Cr | ₹0.43 Cr | ₹0.39 Cr | ₹0.49 Cr | ₹0.23 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.04 Cr | ₹0.05 Cr | ₹0.07 Cr | ₹0.01 Cr | ₹0.00 Cr |
Other current_assets | ₹0.43 Cr | ₹0.37 Cr | ₹0.32 Cr | ₹0.48 Cr | ₹0.23 Cr |
Short Term Loans and Advances | ₹23 Cr | ₹15 Cr | ₹16 Cr | ₹13 Cr | ₹13 Cr |
Advances recoverable in cash or in kind | ₹22 Cr | ₹14 Cr | ₹15 Cr | ₹13 Cr | ₹13 Cr |
Advance income tax and TDS | ₹0.08 Cr | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹0.59 Cr | ₹0.52 Cr | ₹0.36 Cr | ₹0.32 Cr | ₹0.11 Cr |
Total Current Assets | ₹75 Cr | ₹73 Cr | ₹76 Cr | ₹81 Cr | ₹61 Cr |
Net Current Assets (Including Current Investments) | ₹41 Cr | ₹41 Cr | ₹24 Cr | ₹22 Cr | ₹21 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹80 Cr | ₹79 Cr | ₹81 Cr | ₹86 Cr | ₹66 Cr |
Contingent Liabilities | - | - | - | - | - |
Total Debt | ₹13 Cr | ₹14 Cr | ₹21 Cr | ₹18 Cr | ₹17 Cr |
Book Value | - | 31.26 | 24.99 | 21.26 | 20.27 |
Adjusted Book Value | 3.34 | 3.13 | 2.50 | 2.13 | 2.03 |
Compare Balance Sheet of peers of VAISHALI PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VAISHALI PHARMA | ₹207.0 Cr | -8% | 4.8% | 0.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,697.0 Cr | -2% | -0.8% | 16.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,449.0 Cr | -2.7% | 3.5% | 66.7% | Stock Analytics | |
CIPLA | ₹117,778.0 Cr | 0.7% | 1.4% | 3.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,871.0 Cr | 0.1% | -8.5% | 0.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,046.2 Cr | -0.9% | -1% | 24% | Stock Analytics |
VAISHALI PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VAISHALI PHARMA | -8% |
4.8% |
0.5% |
SENSEX | 0.2% |
-0.1% |
7.2% |
You may also like the below Video Courses